Abstract:Background:Arrhythmogenic cardiomyopathy (ACM) manifests with sudden death, arrhythmias, heart failure, apoptosis, and myocardial fibro-adipogenesis. The phenotype typically starts at the epicardium and advances transmurally. Mutations in genes encoding desmosome proteins, including DSP (desmoplakin), are major causes of ACM.Methods:To delineate contributions of the epicardium to the pathogenesis of ACM, the Dsp allele was conditionally deleted in the epicardial cells in mice upon expression of tamoxifen-inducible Cre from the Wt1 locus. Wild type (WT) and Wt1-Cre(ERT2):Dsp(W/F) were crossed to Rosa26(mT/mG) (R26(mT/mG)) dual reporter mice to tag the epicardial-derived cells with the EGFP (enhanced green fluorescent protein) reporter protein. Tagged epicardial-derived cells from adult Wt1-Cre(ERT2):R26(mT/mG) and Wt1-Cre(ERT2): R26(mT/mG):Dsp(W/F) mouse hearts were isolated by fluorescence-activated cell staining and sequenced by single-cell RNA sequencing.Results:WT1 (Wilms tumor 1) expression was progressively restricted postnatally and was exclusive to the epicardium by postnatal day 21. Expression of Dsp was reduced in the epicardial cells but not in cardiac myocytes in the Wt1-Cre(ERT2):Dsp(W/F) mice. The Wt1-Cre(ERT2):Dsp(W/F) mice exhibited premature death, cardiac dysfunction, arrhythmias, myocardial fibro-adipogenesis, and apoptosis. Single-cell RNA sequencing of approximate to 18 000 EGFP-tagged epicardial-derived cells identified genotype-independent clusters of endothelial cells, fibroblasts, epithelial cells, and a very small cluster of cardiac myocytes, which were confirmed on coimmunofluorescence staining of the myocardial sections. Differentially expressed genes between the paired clusters in the 2 genotypes predicted activation of the inflammatory and mitotic pathways-including the TGF beta 1 (transforming growth factor beta 1) and fibroblast growth factors-in the epicardial-derived fibroblast and epithelial clusters, but predicted their suppression in the endothelial cell cluster. The findings were corroborated by analysis of gene expression in the pooled RNA-sequencing data, which identified predominant dysregulation of genes involved in epithelial-mesenchymal transition, and dysregulation of 146 genes encoding the secreted proteins (secretome), including genes in the TGF beta 1 pathway. Activation of the TGF beta 1 and its colocalization with fibrosis in the Wt1-Cre(ERT2):R26(mT/mG):Dsp(W/F) mouse heart was validated by complementary methods.Conclusions:Epicardial-derived cardiac fibroblasts and epithelial cells express paracrine factors, including TGF beta 1 and fibroblast growth factors, which mediate epithelial-mesenchymal transition, and contribute to the pathogenesis of myocardial fibrosis, apoptosis, arrhythmias, and cardiac dysfunction in a mouse model of ACM. The findings uncover contributions of the epicardial-derived cells to the pathogenesis of ACM.

Next-generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy

LV-predominant arrhythmogenic cardiomyopathy related to pathogenic DSP-variant

Case Report of Familial Sudden Cardiac Death Caused by a DSG2 P.f531c Mutation As Genetic Background when Carrying with Heterozygous KCNE5 P.d92e/e93x Mutation

Identification of a LMNA (c.646c > T) Variant by Whole-Exome Sequencing in Combination with a Dilated Cardiomyopathy (DCM) Related Gene Filter in a Family with Familiar DCM

Case report: Additional variants induced sudden cardiac death among pediatric ACM with DSG2 homozygous mutant genotype: a report of three cases

Whole-Exome Sequencing Identifies Y1495x of Scn5a to Be Associated with Familial Conduction Disease and Sudden Death

Whole-exome Sequencing Identified a Novel Desmoglein-2 Gene Mutation Associated with Familial Arrhythmogenic Right Ventricular Cardiomyopathy

An induced pluripotent stem cell line (EHTJUi004-A) generated from a neonate with c.4683_4684delCT:p.Leu1563fs mutation in the gene <i>DSP</i> causing Familial Arrhythmogenic Right Ventricular Dysplasia (ARVD)

Malignant Arrhythmia with Variants of Desmocollin-2 and Desmoplakin Genes.

Molecular insight into arrhythmogenic cardiomyopathy caused by DSG2 mutations

GW24-e0318 Analysis of SCN5A Mutation in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia

Single-Cell Rna Sequencing Uncovers Paracrine Functions Of The Epicardial-Derived Cells In Arrhythmogenic Cardiomyopathy

Desmoplakin CSM models unravel mechanisms regulating the binding to intermediate filaments and putative therapeutics for cardiocutaneous diseases

A Novel Genotype-Based Clinicopathology Classification of Arrhythmogenic Cardiomyopathy Provides Novel Insights into Disease Progression.

Compound and Heterozygous Mutations of DSG2 Identified by Whole Exome Sequencing in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia with Ventricular Tachycardia.

Genetic Mutation of Familial Dilated Cardiomyopathy Based on Next‑generation Semiconductor Sequencing.

Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy

Case report: Whole-exome sequencing identifies a novel DES mutation (p. E434K) in a Chinese family with cardiomyopathy and sudden cardiac death

Clinical features and outcomes in carriers of pathogenic desmoplakin variants

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

Young and Early‐onset Dilated Cardiomyopathy with Malignant Ventricular Arrhythmia and Sudden Cardiac Death Induced by the Heterozygous LDB3, MYH6, and SYNE1 Missense Mutations